Macrolide Resistance Mediated by a Bifidobacterium Breve Membrane Protein

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.49.10.4379-4381.2005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Cellodextrin Utilization by Bifidobacterium Breve UCC2003

Applied and Environmental Microbiology
Applied MicrobiologyBiotechnologyEcologyFood Science
2011English

Induction of Efflux-Mediated Macrolide Resistance in Streptococcus Pneumoniae

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2011English

Efflux-Mediated Aminoglycoside and Macrolide Resistance in Burkholderia Pseudomallei

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1999English

The ClgR Protein Regulates Transcription of the clpP Operon in Bifidobacterium Breve UCC 2003

Journal of Bacteriology
MicrobiologyMolecular Biology
2005English

Membrane Composition-Mediated Protein-Protein Interactions

Biointerphases
Materials ScienceAstronomyGeneticsMolecular BiologyBiochemistryBiomaterialsChemistryPhysics
2008English

Emerging Erm(B)-Mediated Macrolide Resistance Associated With Novel MDRGIs in Campylobacter

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Comparative Genomics and Genotype-Phenotype Associations in Bifidobacterium Breve

Scientific Reports
Multidisciplinary
2018English

Macrolide Resistance in Streptococcus SPP

The Lancet Infectious Diseases
Infectious Diseases
2019English

Benefits of Bifidobacterium Breve M-16v Supplementation in Preterm Neonates - A Retrospective Cohort Study

PLoS ONE
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy